Atlanta, GA, United States of America

Christopher B Doering

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Lee's Summit, MO (US) (2009)
  • Atlanta, GA (US) (2018 - 2024)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Christopher B Doering

Introduction: Christopher B Doering is a prominent inventor based in Atlanta, GA, known for his contributions to the fields of biotechnology and medical devices. With an impressive portfolio of 13 patents, his innovative work focuses on enhancing transduction efficiency and developing recombinant proteins for treating bleeding disorders.

Latest Patents: Among his notable patents, Christopher has developed several methods and devices aimed at improving transduction processes. One of his latest patents, titled "Methods, devices and systems for enhanced transduction efficiency," addresses diffusion limitations in current systems by utilizing channel geometry and configuration. This invention outlines a method of transducing target cells using a device equipped with at least one continuous channel. The process involves delivering target cells and viral vectors into the transduction region, followed by a flushing solution to collect the transduced cells.

Another significant patent is for "Von Willebrand factor proteins for treating bleeding disorders." This patent describes a recombinant von Willebrand Factor (VWF) protein designed to include mutations and outlines its various applications. The invention includes protein complexes combining von Willebrand factor and Factor VIII sequences, nucleic acid sequences, and vectors encoding VWF sequences, as well as pharmaceutical compositions aimed at inducing blood clotting.

Career Highlights: Christopher has made significant contributions during his career, particularly through his roles at leading institutions. He has worked at Emory University and Children's Healthcare of Atlanta, Inc., where he has advanced the fields of biotechnology and healthcare. His dedication to research and innovation has directly impacted patient care and treatment methodologies.

Collaborations: Throughout his career, Christopher has collaborated with esteemed colleagues, including H Trent Spencer and Eric Gaucher. These partnerships have fostered a collaborative environment that has fueled ground-breaking innovations and research projects.

Conclusion: Christopher B Doering continues to be a key player in the realm of biotechnology, with his inventive spirit driving advancements that have the potential to transform treatment options for various medical conditions. As he builds on his successful career, the landscape of health innovations remains optimistic with his contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…